Bottom line
What is CATH's expense ratio?
CATH's expense ratio is 0.29%, or about $29 a year on every $10,000 invested. That is cheaper than 95% of global stock funds we track (median 0.95%).
Updated Feb 26, 2026
CATH fee table
| Net expense ratio | 0.29% |
|---|---|
| Gross expense ratio | 0.29% |
| Management fee | 0.29% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0% |
| Max front-end sales load | None (ETF) |
Source: Fund prospectus fee table, filed Feb 26, 2026
What CATH costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CATH | $30 | $93 | $163 | $368 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.29% expense ratio costs roughly $17,100 in lost growth, versus about $52,800 for the median global stock fund (0.95%).
Cheaper alternatives to CATH
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.